ATRA activates and PDGF-BB represses the SM22α promoter through KLF4 binding to, or dissociating from, its cis-DNA elements

Cardiovasc Res. 2011 Jun 1;90(3):464-74. doi: 10.1093/cvr/cvr017. Epub 2011 Jan 20.

Abstract

Aims: Krüppel-like factor 4 (KLF4) is implicated in all-trans retinoic acid (ATRA)-induced and platelet-derived growth factor-BB (PDGF-BB)-repressed SM22α expression in vascular smooth muscle cells (VSMCs). However, its exact mechanism of action remains unclear. We determined how KLF4 plays different roles in ATRA- and PDGF-BB-dependent regulation of the SM22α gene.

Methods and results: ATRA and PDGF-BB induced KLF4 expression but exhibited an opposite effect on SM22α expression and VSMC proliferation. Chromatin immunoprecipitation and oligonucleotide pull-down assays showed that KLF4 was directly bound to the KLF4 binding sites 1 ((-263)CACCC(-259)) and 2 ((-136)GTGGG(-132)) of the SM22α promoter. ATRA increased the binding of KLF4 to site 2, whereas PDGF-BB decreased the binding of KLF4 to site 1. ATRA stimulated KLF4 acetylation by inducing KLF4 phosphorylation and increasing its interaction with p300 via activating c-Jun NH(2)-terminal kinase (JNK) and p38 pathways, and acetylated KLF4 increased its binding activity to site 2. PDGF-BB stimulated KLF4 deacetylation by inducing KLF4 dephosphorylation and increasing its interaction with histone deacetylase 2 (HDAC2) via activating extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase/Akt (PI3K/Akt) pathways, and deacetylated KLF4 dissociated from site 1.

Conclusions: In VSMCs, ATRA activates and PDGF-BB represses SM22α expression through KLF4 binding to, or dissociating from, its different cis-elements in an acetylation-dependent manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • Base Sequence
  • Becaplermin
  • Binding Sites / genetics
  • Cells, Cultured
  • DNA / genetics
  • DNA / metabolism
  • Gene Expression / drug effects
  • Gene Knockdown Techniques
  • Histone Deacetylase 2 / metabolism
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Kruppel-Like Factor 4
  • Kruppel-Like Transcription Factors / antagonists & inhibitors
  • Kruppel-Like Transcription Factors / genetics
  • Kruppel-Like Transcription Factors / metabolism*
  • MAP Kinase Signaling System / drug effects
  • Microfilament Proteins / genetics*
  • Muscle Proteins / genetics*
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism
  • Platelet-Derived Growth Factor / pharmacology*
  • Promoter Regions, Genetic / drug effects
  • Protein Binding / drug effects
  • Proto-Oncogene Proteins c-sis
  • RNA, Small Interfering / genetics
  • Rats
  • Signal Transduction / drug effects
  • Tretinoin / pharmacology*
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Klf4 protein, rat
  • Kruppel-Like Factor 4
  • Kruppel-Like Transcription Factors
  • Microfilament Proteins
  • Muscle Proteins
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • RNA, Small Interfering
  • transgelin
  • Becaplermin
  • Tretinoin
  • DNA
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Hdac2 protein, rat
  • Histone Deacetylase 2